DNA Genetics: A Leader in Cannabis Branding & Licensing
Ryan Allway
June 24th, 2019
App, Exclusive, News, Top News
The cannabis industry is projected to reach $146.4 billion by 2025, according to Grand View Research, representing a 34.6% compound annual growth rate. While many companies are focused on cultivation and retail, these business models involve high capital expenditures to produce commoditized products. Investors may be better off looking at companies focused on branding and licensing given the lower capital expenditure and competitive barriers.
DNA Genetics, co-founded by Don Morris and Aaron Yarkoni, is one of the oldest and most established cannabis brands in the industry with a vast library of highly sought after and award-winning strains. With wholly-owned subsidiaries in California and Amsterdam, the company is uniquely positioned to expand into both North American and European markets through strategic brand and cultivar licensing deals capable of generating high margin recurring income for shareholders.
Click here to receive an Investor Presentation and Company Updates
In this article, we will take a look at the company’s portfolio of award-winning strains as well as its unique business model that already is scaling into markets worldwide.
Award Winning Strains
DNA Genetics has amassed more than 200 awards in all categories at the most prestigious cannabis events around the world, making DNA a global standard in breeding and growing truly best-in-class cultivars. Such awards include the High Times ‘Top 10 Strain of the Year’, which was inducted into The High Times Seedbank Hall of Fame in 2019. Co-founders Don and Aaron have also been recognized for their contributions to the industry, having been named as part of High Times’ 100 Most Influential People in Cannabis and receiving the High Times Trail Blazers Award for contributions made towards uniting the fields of entrepreneurship, politics and medicine. In addition to its in-house strains, the company owns the rights to the Crockett Family Farms’ entire line-up, which are known for their exceptional flavor profiles. These strains promote high-yield production, pharmacological efficacy, and consumer interest.
The company markets these strains through an online and televised media presence. In the near future, the company’s founders will be featured on Pimp My Grow, a new video series, where Don and Aaron team up with Cypress Hill’s B-Real. They travel across the country turning amateur grows into industrial operations. The episode will appear on the PROHBTD Media Network—the first and largest cannabis lifestyle video network in the world.
Unique Business Model
DNA Genetics has developed a licensing platform that is designed to keep capital expenditures low and profit margins high. License agreements are designed on a case-by-case basis with varying royalty terms, exclusivity rights and best practice consulting on the licensee’s scale and markets in which they operate. These licensing agreements produce high margin, recurring revenue over time.
Click here to receive an Investor Presentation and Company Updates
For example, the company licenses its brands and genetics to Canopy Growth Corp. (TSX: WEED) (NYSE: CGC)—the largest cannabis company in the world based on market capitalization—for use in its highest priced products. In March, DNA and Canopy extended their partnership through 2024 and expanded it to include select European markets.
The company has agreements in place in Canada, Europe and several U.S. states. Management projects to reach 12 states and five countries by the end of 2020, and ultimately expand to reach 20 states and ten countries by 2021. The company will also release its own product offering in California, where its brand is well positioned at the top of the world’s largest cannabis market.
Looking Ahead
DNA Genetics is one of the oldest and most established cannabis brands in the industry with ambitious plans to grow its footprint over the coming years. Investors may want to keep an eye on the company as it looks to become a publicly-traded entity over the coming quarters.
For more information, visit the company’s website at www.dnagenetics.com
Click here to receive an Investor Presentation and Company Updates
Disclaimer
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation:https://cannabisfn.com/legal-disclaimer/
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Watch CFN Media’s exclusive three part interview with Paul Rosen, one of the most active and diversified investors in the emerging cannabis industry. Paul gives his insights on the global cannabis industry and discusses his new endeavors. Become a CFN Media Client Paul Rosen is a noted career entrepreneur and management consultant. Over the last […]
Rob is the co-founding President of Pelorus Equity Group and has more than 18 years of experience in the real estate finance industry. Since the formation of Pelorus in 2010, he has raised more than $175,000,000 in secured real estate transactions. Rob’s primary role at Pelorus Equity Group is the development of strategic alliances with […]
Empower Inc. (CSE: EPW) is a growing network of physician-staffed health clinics focused on helping patients improve and protect their health.
Creso was created to bring pharmaceutical expertise and methodological rigour to the world of cannabis and deliver quality products to people and animals everywhere.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
